Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT

Geert M. Verleden; Allan R. Glanville; Erika D. Lease; Andrew J. Fisher; Fiorella Calabrese; Paul A. Corris; Christopher R. Ensor; Jens Gottlieb; Ramsey R. Hachem; Vibha Lama; Tereza Martinu; Desley A.H. Neil; Lianne G. Singer; Greg Snell; Robin Vos

doi:10.1016/j.healun.2019.03.009

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT

Geert M. Verleden, Allan R. Glanville, Erika D. Lease, Andrew J. Fisher, Fiorella Calabrese, Paul A. Corris, Christopher R. Ensor, Jens Gottlieb, Ramsey R. Hachem, Vibha Lama, Tereza Martinu, Desley A.H. Neil, Lianne G. Singer, Greg Snell, Robin Vos

Research output: Contribution to journal › Editorial

625 Scopus citations

Original language	English
Pages (from-to)	493-503
Number of pages	11
Journal	Journal of Heart and Lung Transplantation
Volume	38
Issue number	5
DOIs	https://doi.org/10.1016/j.healun.2019.03.009
State	Published - May 2019

Access to Document

10.1016/j.healun.2019.03.009

Cite this

Verleden, G. M., Glanville, A. R., Lease, E. D., Fisher, A. J., Calabrese, F., Corris, P. A., Ensor, C. R., Gottlieb, J., Hachem, R. R., Lama, V., Martinu, T., Neil, D. A. H., Singer, L. G., Snell, G., & Vos, R. (2019). Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT. Journal of Heart and Lung Transplantation, 38(5), 493-503. https://doi.org/10.1016/j.healun.2019.03.009

@article{17636ec1e48e4060bea4c0425f4ffd42,

title = "Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT",

author = "Verleden, {Geert M.} and Glanville, {Allan R.} and Lease, {Erika D.} and Fisher, {Andrew J.} and Fiorella Calabrese and Corris, {Paul A.} and Ensor, {Christopher R.} and Jens Gottlieb and Hachem, {Ramsey R.} and Vibha Lama and Tereza Martinu and Neil, {Desley A.H.} and Singer, {Lianne G.} and Greg Snell and Robin Vos",

note = "Funding Information: J.G. has received research grants from Roche and Gilead, honoraria from consultancy, advisory and or lectures from Boehringer, Gilead, MSD, Biotest, Therakos, Novartis, Cbiesi, Breath Therapeutics, Adept, GLG research and Astellas. Ramsey Haqchem reports grants from Bristol Meyers Squibb and Threakos, and honoraria for advisroy boards from Theravance and vectura. Christopher Ensor reports grans from Amgen and CSL Begring. The other authors have no potential financial conflicts of interest to disclose. All authors attest that no funding has been received fom any source for this work.",

year = "2019",

month = may,

doi = "10.1016/j.healun.2019.03.009",

language = "English",

volume = "38",

pages = "493--503",

journal = "Journal of Heart and Lung Transplantation",

issn = "1053-2498",

number = "5",

}

Verleden, GM, Glanville, AR, Lease, ED, Fisher, AJ, Calabrese, F, Corris, PA, Ensor, CR, Gottlieb, J, Hachem, RR, Lama, V, Martinu, T, Neil, DAH, Singer, LG, Snell, G & Vos, R 2019, 'Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT', Journal of Heart and Lung Transplantation, vol. 38, no. 5, pp. 493-503. https://doi.org/10.1016/j.healun.2019.03.009

TY - JOUR

T1 - Chronic lung allograft dysfunction

T2 - Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT

AU - Verleden, Geert M.

AU - Glanville, Allan R.

AU - Lease, Erika D.

AU - Fisher, Andrew J.

AU - Calabrese, Fiorella

AU - Corris, Paul A.

AU - Ensor, Christopher R.

AU - Gottlieb, Jens

AU - Hachem, Ramsey R.

AU - Lama, Vibha

AU - Martinu, Tereza

AU - Neil, Desley A.H.

AU - Singer, Lianne G.

AU - Snell, Greg

AU - Vos, Robin

N1 - Funding Information: J.G. has received research grants from Roche and Gilead, honoraria from consultancy, advisory and or lectures from Boehringer, Gilead, MSD, Biotest, Therakos, Novartis, Cbiesi, Breath Therapeutics, Adept, GLG research and Astellas. Ramsey Haqchem reports grants from Bristol Meyers Squibb and Threakos, and honoraria for advisroy boards from Theravance and vectura. Christopher Ensor reports grans from Amgen and CSL Begring. The other authors have no potential financial conflicts of interest to disclose. All authors attest that no funding has been received fom any source for this work.

PY - 2019/5

Y1 - 2019/5

UR - http://www.scopus.com/inward/record.url?scp=85061320346&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2019.03.009

DO - 10.1016/j.healun.2019.03.009

M3 - Editorial

C2 - 30962148

AN - SCOPUS:85061320346

SN - 1053-2498

VL - 38

SP - 493

EP - 503

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

IS - 5

ER -

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT

Access to Document

Other files and links

Cite this